Thinh Q. Pham - Concepedia

Author

Thinh Q. Pham

Also Known As

Thinh Pham, Thinh Q Pham, Thinh Q. Pham

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Thinh Q. Pham is an author at Discovery Centre specializing in medicine, systems biology, and tumor biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	122
2	Cell Biology	2	2	122
3	Cancer Genetics	2	2	122
4	Molecular Genetics	1	1	65
5	Cancer Cell Biology	1	1	57

Thinh Q. Pham

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
A Central Role for HER3 in <i>HER2</i> -Amplified Breast Cancer: Implications for Targeted Therapy Si Tuen Lee-Hoeflich, Lisa Crocker, Evelyn Yao, Cancer Research	2008	642
Epithelial versus Mesenchymal Phenotype Determines <i>In vitro</i> Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients Robert L. Yauch, Thomas Januario, David A. Eberhard, Clinical Cancer Research	2005	489
Clinical Activity of Pertuzumab (rhuMAb 2C4), a HER Dimerization Inhibitor, in Advanced Ovarian Cancer: Potential Predictive Relationship With Tumor HER2 Activation Status Michael S. Gordon, Daniela Matei, Carol Aghajanian, Journal of Clinical Oncology	2006	249
Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure Cristi L. Galindo, Michael A. Skinner, Mounir Errami, BMC Physiology	2009	103
Oncogenic Activating Mutations Are Associated with Local Copy Gain Barmak Modrek, Lin Ge, Ajay Pandita, Molecular Cancer Research Local Copy GainSomatic VariantOncogenic AgentMedicineGenetics	2009	65
PPM1H Is a p27 Phosphatase Implicated in Trastuzumab Resistance Si Tuen Lee-Hoeflich, Thinh Q. Pham, Don Dowbenko, Cancer Discovery Breast OncologyCancer BiologyLow Ppm1h ExpressionTumor BiologySignaling Pathway	2011	57
Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma Nisebita Sahu, Emily Chan, Felix Chu, Molecular Cancer Therapeutics	2017	30

Page 1